Navigation Links
Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques
Date:10/25/2011

g at an accelerating rate thanks to growing clinical experience in multiple surgical specialties and the expansion of our sales channel to global coverage."

About Misonix:

Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment.  Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies.  Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.  Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.  These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.  Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding stra
'/>"/>

SOURCE Misonix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
5. Misonix Announces New Distribution Agreement for Mexico
6. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
7. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
8. Misonix Announces New Distribution Agreement for Peru
9. Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
10. Misonix Announces New Distribution Agreement for Argentina
11. Misonix Announces New Distribution Agreement for Kingdom of Saudi Arabia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... in New York, NY on ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
(Date:7/1/2015)... Pa. , July 1, 2015 Precyse, ... and education, announced today that, as part of its ... an agreement to be acquired by investment firm Pamplona ... private equity investors, Altaris Capital Partners and NewSpring Capital, ... in 1999, has assisted nearly 5,000 healthcare facilities and ...
(Date:7/1/2015)... DUBLIN , June 24, 2015 ... has announced the addition of the "2015 ... to their offering. This new 175-page ... market segments, including diabetes (strips and meters), pregnancy, ... dynamics, size, growth, regulatory requirements, technologies, and competitive ...
Breaking Medicine Technology:ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 32015 Strategies in the Home/Self Testing Market 2
... Instruments Incorporated (TI) (NASDAQ: TXN ) today ... with five new fully integrated AFEs for portable biopotential ... AFEs are the first to offer 16- and 24-bit ... power consumption by more than 94 percent compared to ...
... April 4, 2012  UCB (Euronext Brussels: UCB) and Amgen ... of their sclerostin antibody (CDP7851/AMG 785) Phase 3 clinical ... "We look forward to working with UCB on ... Harper, M.D., executive vice president of Research and Development ...
Cached Medicine Technology:TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 2TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 3TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 4TI introduces industry's first single- and dual-channel, 16- and 24-bit ECG/EEG analog front ends 5UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 2UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 3UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 4UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 5UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 6UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis 7
(Date:7/1/2015)... ... July 01, 2015 , ... ... new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of the ... DIC Group’s U.S. Spirulina* production base, began in May 2014. After commissioning, commercial ...
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... Summer ... taboo with teenagers to fix noses and chins with plastic surgery when they’re looking ... Surgeons (ASPS) more than 236,000 cosmetic procedures were performed on patients ages 19 and ...
(Date:7/1/2015)... Humble, TX (PRWEB) , ... July 01, 2015 , ... ... also another symptom found in a significant number of women: leg pain. Northeast Houston ... , Leg pain, a symptom of venous reflux disease, is underdiagnosed and often ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in which the ... Scoliosis Foundation, it affects 2 to 3 percent of the population, or an estimated 6 ... often develops in children between the ages of 10 and 15. Most types of scoliosis ...
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... ... treatment, announces their big summer sale. Customers purchasing two or more Bunion ... code "Summer15". , Bunion Bootie temporarily corrects misaligned toes and its ...
Breaking Medicine News(10 mins):Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... high and there are certain ultrasound features, suggesting malignancy, ... biopsy is needed, according to a study performed at ... Francisco, CA. , A total of 245 patients ... were analyzed. "Our study supports previous data showing that ...
... effective colorectal screening test, is feasible in rural health centers ... at the University of Arizona in Tucson, AZ. ... at two remote medical centers (343 and 337 miles from ... patients and the data obtained was then sent to a ...
... following 62-cent increase on cigarettesMINNEAPOLIS, April 23 ... a lot of Minnesotans trying to quit smoking. ... ClearWay Minnesota(SM), has seen user volumes spike following ... by 62 cents to expand the ...
... DALLAS, April 23 Two hundred forty-two pages of ... translated into Traditional Chinese and is now available on ... www.americanheart.org . The Traditional Chinese ... already offers content in Spanish, Vietnamese and Simplified Chinese. ...
... Mass., April 23 The Harvard Graduate School ... development institute to help academic leaders, practitioners and faculty ... The Connecting the Mind, Brain, and Education ... the brain and how it functions can improve the ...
... 23, 2009 During the past several years, significant ... nicotine dependence through genetic linkage and association analyses. ... with tobacco smoking, only a very limited number of ... find these functional variants and then characterize them remains ...
Cached Medicine News:Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 3Health News:American Heart Association Web Site Now Offers Content Translated Into Traditional Chinese 2Health News:Bringing Brain Science to the Classroom 2Health News:Throwing the micro switch: MicroRNA may link smoking risk gene to neurobiology of addiction 2
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: